Nico Gagelmann/X
Dec 3, 2024, 18:12
Nico Gagelmann: Happy to present first European comparison of cilta-cel vs ide-cel for myeloma at ASH24
Nico Gagelmann, Co-chair of EBMT’s Trainee Committee, shared on X:
“Happy to present first European comparison of cilta-cel vs ide-cel for myeloma ASH24:
-Cilta-cel with better ORR, CR, PFS
-Similar NRM
-Peak CAR-T expansion day 14 for cilta-cel vs day 7 for ide-cel
Associated with response and with ICANS for cilta-cel.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 6, 2025, 19:32
Jan 6, 2025, 19:23
Jan 6, 2025, 19:21
Jan 6, 2025, 19:13
Jan 6, 2025, 19:09
Jan 6, 2025, 17:15
Jan 6, 2025, 17:07
Jan 6, 2025, 16:37